Elecsys Brahms PCT

The Elecsys B·R·A·H·M·S PCT is an automated electrochemiluminescence immunoassay (ECLIA) developed by Roche in collaboration with B·R·A·H·M·S. It is used for the quantitative determination of procalcitonin (PCT) in human serum or plasma to aid in the early detection and management of bacterial infections and sepsis.

Clinical Applications

  • Sepsis Risk Assessment: Evaluates the risk of critically ill patients progressing to severe sepsis or septic shock on their first day of ICU admission.
  • Antibiotic Stewardship: Helps clinicians decide when to initiate, monitor, or discontinue antibiotic therapy, particularly in patients with lower respiratory tract infections (LRTI) or sepsis.
  • Mortality Prediction: Assists in assessing the 28-day cumulative risk of all-cause mortality for patients diagnosed with severe sepsis or septic shock.

Manufacturer: Roche Diagnostics GmbH

Addresses:

  • Sandhofer Straße 116, 68305 Mannheim, Germany


Product Prices:

The pricing for Elecsys B·R·A·H·M·S PCT varies significantly depending on whether you are purchasing laboratory reagent kits or the clinical test itself as a patient.

Reagent & Kit Pricing (Laboratory Use)

Reagents are typically sold in packs of 100 tests. Prices fluctuate by region and distributor:

  • 100-Test Kit: Prices for the standard reagent pack (e.g., Material No. 08828644190) range from approximately €620 to €975 ($650 to $1,030 USD).
  • 300-Test Kit: Larger formats for high-volume analyzers (e.g., cobas e 801) are also available, with prices scaling accordingly.
  • Ancillary Costs: Calibrators and controls (like PreciControl PCT) are often sold separately or bundled in specific contracts.

Clinical Test Costs (For Patients)

The cost to a patient or healthcare institution per individual test run is influenced by laboratory overhead and regional healthcare policies:

  • United States: The average cost for a procalcitonin test is approximately $70 per test.
  • .International Trends: Pricing for the Elecsys platform has seen a downward trend in European markets (such as Italy and Switzerland) as of recent years due to increased competition and bulk purchasing agreements.

For official institutional pricing, healthcare providers should consult the Roche Diagnostics Price List or contact a local Roche representative.

Free References


Comparative analysis of Access PCT and Elecsys BRAHMS PCT assays for procalcitonin measurements


Analytical Evaluation of Point-of-Care Finecare™ Procalcitonin Rapid Quantitative Test in Sepsis Population as Compared with Elecsys® BRAHMS Procalcitonin Immunoassay


Comparison of a novel automated DiaSys procalcitonin immunoassay with four different BRAHMS-partnered immunoassays

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *